发明名称 Modified peptides as therapeutic agents
摘要 The present invention concerns fusion of Fc domains with Ang-2 binding peptides and a process for preparing such molecules. In this invention, pharmacologically active compounds are prepared by a process comprising (a) selecting at least one random peptide that binds to Ang-2; and (b) preparing a pharmacologic agent comprising an Fc domain covalently linked to at least one amino acid of the selected peptide. Linkage to the vehicle increases the half-life of the peptide, which otherwise would be quickly degraded in vivo. The preferred vehicle is an Fc domain. The peptide can be selected, for example, by phage display, E. coli display, ribosome display, RNA-peptide screening, yeast-based screening, chemical-peptide screening, rational design, or protein structural analysis.
申请公布号 US2006234307(A1) 申请公布日期 2006.10.19
申请号 US20060472070 申请日期 2006.06.20
申请人 AMGEN INC. 发明人 FEIGE ULRICH;LIU CHUAN-FA;CHEETHAM JANET C.;BOONE THOMAS C.;GUDAS JEAN M.
分类号 C12N15/02;C40B40/10;A61K47/48;A61P3/02;A61P7/04;A61P7/06;A61P13/02;A61P17/02;A61P31/18;A61P35/04;A61P37/02;A61P43/00;C07H21/04;C07K14/505;C07K14/52;C07K14/545;C07K16/18;C07K16/46;C07K19/00;C12N1/21;C12N15/74;C12P21/06;C12P21/08;C12R1/19 主分类号 C12N15/02
代理机构 代理人
主权项
地址